Clinical Trial: A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07766369) titled 'A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants' on Aug. 11.

Brief Summary: The primary purpose of this study is to assess potential drug-drug interactions of E2086 when coadministered orally with Itraconazole, Carbamazepine, Midazolam, Dextromethorphan, Bupropion, or Combined Oral Contraceptives in Healthy Participants

Study Start Date: Aug. 12

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: E2086

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eisai Inc.

Disclaimer: Curated by HT Syndication....